This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Mobilizing Character
Thomas WatsonArticle IVEY-W28146-ELeadership and People ManagementUkrainian president Volodymyr Zelensky is a skilled actor, but that’s not what makes him an invaluable leadership role model for his people and the rest of our troubled world.Starting at €8.20
-
The Notorious Leadership of Ruth Bader Ginsburg
Mary Crossan; Larry Crossan; Thomas WatsonArticle IVEY-9B20TE03-ELeadership and People ManagementFor people who aspire to drive change, studying the impact that character had on RBG’s judgment is as important as replicating her commitment and competenceStarting at €8.20
-
Report from the Front Lines of Workplace Disruption
Thomas WatsonArticle IVEY-9B21TA02-ELeadership and People ManagementWorking in HR following the COVID-19 outbreak and global protests over systemic racism is like climbing a steep mountain, on your own, in the dark, without a rope, during a perfect storm.Starting at €8.20
-
Leadership Lessons from the Pandemic (and Samwise Gamgee)
Thomas Watson; Gerard SeijtsArticle IVEY-9B20TD07-ELeadership and People ManagementWhy today’s business leaders need to show that great stories about fighting for what really matters can exist beyond fiction.Starting at €8.20
-
Revera Inc. Getting Alignment Workshop (C)
Gerard Seijts; Thomas WatsonCase IVEY-9B20C013-ELeadership and People ManagementSupplement for product 9B20C011.Starting at €5.74
-
New Immuno-Oncology Solutions (NIOS): Aligning Stakeholders in the Biotech Industry
Vroom, Govert; Maribel Berges; Sastre Boquet, IsaacCase SM-1701-EEntrepreneurship, Innovation and Change, StrategyThis case focuses on a small biotech company (NIOS), located in Barcelona, Spain, that is developing a new immune-oncology product for treating pancreatic cancer. The drug that the company is developing has recently finished Phase I of clinical trials successfully and is now preparing for Phase II and III. At this point, the CEO is approached by her former PhD director, a university professor, who asks if the company is interested in licensing a ...Starting at €8.20
-
Tweetledee Tweetledumb
Thomas WatsonArticle IVEY-9B17TA02-EStrategyWhen it comes to the threat posed by Donald Trump’s Twitter feed, the real problem is how businesses are being told to react.Starting at €8.20
-
Judgment Play
Thomas WatsonArticle IVEY-9B16TC04-ELeadership and People ManagementIt is easy to blame corporate fraud and financial-sector misconduct on a lack of morals. But framing the issue of businesses behaving badly strictly as a morality problem is problematic because it leads to solutions — ranging from expanded compliance programs and codes of conduct to compensation claw-back clauses — that aim to install and strengthen moral sensibilities for the purpose of positive behaviour modification. And these have proved larg...Starting at €8.20
-
Q&A with Hap Klopp
Thomas WatsonArticle IVEY-9B15TF03-EStrategyHap Klopp founded The North Face, where he served as president and CEO for 20 years and built the largest and most successful retailer in its industry. In this Ivey Interview, he discusses lessons learned over his impressive career and warns against businesses looking to get rich overnight, because for every Silicon Valley success story there are countless failures and disappointments. The North Face is an example of disruptive technology, as it ...Starting at €8.20
-
Fighting Shareholder Populism
Thomas WatsonArticle IVEY-9B19TE01-ELeadership and People ManagementThanks to the spread of populism, corporate directors and managers need to get ready to rumble like never before as weak oversight enables activist investors to manipulate emotions during digital-age proxy fights.Starting at €8.20